Caplacizumab (ALX-0681), a humanized anti-von Willebrand factor (vWF) nanobody, serves to impede vWF-mediated platelet adhesion, thereby averting additional microthrombi formation. This compound is utilized in the study of thrombotic thrombocytopenic purpura (TTP) [1].
CAS Number:
[915810-67-2]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted